MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-09-2023
Applied Molecular Transport EBITDA per Share 2011-2026 | AMTI
Annual EBITDA per Share Applied Molecular Transport
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.2 | -2.59 | -2.83 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.59 | -3.2 | -2.87 |
Quarterly EBITDA per Share Applied Molecular Transport
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.45 | -0.71 | - | -0.64 | -0.91 | -1.08 | - | -0.61 | -0.6 | -0.56 | - | -0.45 | -1.06 | -2.05 | - | -1.05 | -0.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.45 | -2.05 | -0.858 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-0.71 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
0.08 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-23.7 | - | - | $ 269 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
-1.05 | $ 0.77 | -4.12 % | $ 35.2 M |  Israel |
 |
Exelixis
EXEL
|
3.32 | $ 48.16 | 4.22 % | $ 13.1 B | USA |
 |
BioNTech SE
BNTX
|
-5.81 | $ 94.13 | 1.19 % | $ 22.8 B | Germany |
 |
Fortress Biotech
FBIO
|
-2.5 | $ 2.39 | -0.42 % | $ 66.7 M | USA |
|
Forte Biosciences
FBRX
|
-5.45 | $ 24.02 | -8.22 % | $ 311 M | USA |
 |
Compugen Ltd.
CGEN
|
-0.41 | $ 2.9 | 1.4 % | $ 271 M | Israel |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
1.4 | $ 22.4 | -0.71 % | $ 3.71 B | USA |
 |
Genmab A/S
GMAB
|
10.4 | $ 26.43 | -2.33 % | $ 1.71 B |  Danmark |
 |
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
0.29 | $ 3.14 | - | $ 653 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 3.51 | -0.85 % | $ 5.78 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | Canada |
 |
Gilead Sciences
GILD
|
8.35 | $ 131.33 | -2.04 % | $ 163 B | USA |
 |
Genprex
GNPX
|
-264 | $ 0.87 | 0.58 % | $ 811 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 21.17 | 2.47 % | $ 2.69 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | USA |
 |
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | USA |
 |
Grifols, S.A.
GRFS
|
1.75 | $ 8.1 | 0.5 % | $ 5.51 B |  Spain |
 |
Aileron Therapeutics
ALRN
|
-1.99 | - | 10.36 % | $ 9.8 M | USA |
 |
Applied Therapeutics
APLT
|
-0.77 | - | - | $ 8.42 M | USA |
 |
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-1.57 | - | 17.91 % | $ 11.1 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-7.17 | $ 54.83 | 4.6 % | $ 4.93 B |  Schweiz |
 |
Avenue Therapeutics
ATXI
|
-0.98 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-0.99 | $ 1.57 | -2.48 % | $ 418 M | Britain |